Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
2.9%
% of FHLC's 369 holdings also in OZEM
43.5%
% of OZEM's 23 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus OZEM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in OZEM |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 14.2% | 10.2% |
|
AMGEN INC | 2.8% | 3.2% | 2.8% |
|
PFIZER INC | 2.7% | 3.0% | 2.7% |
|
REGENERON PHARMACEUTICALS | 1.8% | 2.3% | 1.8% |
|
VIKING THERAPEUTICS, INC. | 0.1% | 3.3% | 0.1% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to OZEM
|
UNITEDHEALTH GROUP INC | 8.3% |
|
JOHNSON & JOHNSON | 6.1% |
|
ABBVIE INC | 5.2% |
|
MERCK & CO. INC. | 5.0% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
DANAHER CORP | 3.0% |
|
ABBOTT LABORATORIES | 2.9% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
|
ELEVANCE HEALTH INC | 1.9% |
FHLC Underweight Relative to OZEM
 |
NOVO-NORDISK A/S-SPONS ADR | -16.9% |
 |
ROCHE HOLDING LTD | -4.9% |
|
ZEALAND PHARMA A/S | -4.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -4.7% |
|
ALTIMMUNE, INC. | -4.6% |
|
ELI LILLY & CO | -3.9% |
 |
ASTRAZENECA PLC-SPONS ADR | -3.9% |
|
VIKING THERAPEUTICS, INC. | -3.2% |
 |
INNOVENT BIOLOGICS, INC. | -3.2% |
|
SCHOLAR ROCK HOLDING CORP. | -2.7% |